Global Ophthalmology Drugs and Devices Market Size, Share, Growth, Outlook and Forecast to 2021: Acute Market Reports

The global ophthalmology drugs and devices market is expected to grow at a CAGR of 7% for the forecasted period of 2015-2021. The market was worth $XX billion in 2014 and is expected to be $XX billion in 2021. The market is driven by various factors which include increase prevalence of eye related disorders such as glaucoma and cataract aging population, regulatory approvals to new drugs and devices, new technologies such as minimally invasive surgical devices, focus on combining drugs and device therapies and increasing economic factors such as rise in disposable income and health expenditure. The market opportunities lie in the growing awareness especially in the emerging and underdeveloped countries, demand for intraocular lenses, phacoemulsification devices and other devices and therapies. However, factors such as expiration of patents, drying pipelines and major slowdowns in economies may hamper the market growth.

The market is segmented on the basis of ophthalmic diagnostic & monitoring equipment market which includes optical coherence tomography scanners market, ultra sound imaging systems, fundus camera market, ophthalmoscopes, retinoscope and other market. The surgical devices include cataract surgery device, intraocular lens market, phacoemulsification devices, glaucoma surgery device market and others. The popular drugs include Lucentis, Eylea, Avastin, Restasis, Lumigan and Ganfort, Xalatan/Xalacom, Pataday and other. The drugs include drugs for glaucoma, retinal disorder, dry eye, allergic conjunctivitis, inflammation and conjunctivitis. The end users include hospitals, eye clinics, diagnostic centres and patients.

The major geographies include North America, Europe, Asia-Pacific and rest of the world. North America is the largest market followed by Europe and Asia pacific. The North American market is driven high awareness, availability of drugs and devices, better regulatory outreach which leads to increased trust in the devices and drugs. Asia Pacific market to have high growth rate driven by strong markets in China and India. Market includes top players such as Abbot Laboratories, Alcon Inc, Ellex Medical lasers ltd, Essilor international S.A., Allergan Inc, Bausch & Lomb Inc, Carl Zeiss Meditec AG, Johnson and Johnson and Hoya Corporation.

Browse For Full Report: http://www.acutemarketreports.com/report/global-ophthalmology-drugs-and-devices-market-by-country-united-states-canada-india-china-japan-united-kingdom-company-profiles-share-trends-analysis-opportunities-segmentation-and-forecast-2015-2021

1. Abbot Laboratories
2. Alcon Inc
3. Ellex Medical lasers ltd
4. Essilor international S.A.
5. Allergan Inc
6. Bausch & Lomb Inc
7. Carl Zeiss Meditec AG
8. Johnson and Johnson
9. Hoya corporation
10. Pfizer Inc
11. Roche holding AG
12. Santen pharmaceutical co. ltd
13. Staar surgical company
14. Iridex corporation
15. Merc & Co. Inc
16. Nidek Co. Ltd
17. Topcon corporation
18. Novagali Pharma S.A.
19. Novartis AG
20. Nicox
21. Acucela
22. Senju
23. Bayer
24. Valeant
25. Regeneron
26. Akorn
27. Eyemed
28. Visioncare ophthalmic technologies
29. Biotech Visioncare
30. VSP

This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR up to 2021
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data

1. Introduction
1.1. Executive summary
1.2. Estimation methodology

2. Market overview
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Prevalence & incidence rate of eye disorders
2.3.2. Hospital and eye clinic across geographies
2.3.3. Increasing cataract surgeries
2.3.4. Healthcare expenditure across geographies
2.3.5. Disposable income of top emerging economies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. Pipeline analysis
2.4.4.1. SHP616:acute neuromyelitis optica
2.4.4.2. SHP622: friedreich’s ataxia
2.4.4.3. SHP606: dry eye disease
2.4.4.4. Lifitegrast: dry eye disease
2.4.4.5. SHP626: non alcoholic steatohepatitis
2.4.4.6. SHP627: focal segmental glomerulosclerosis
2.4.4.7. Guanfacine: (EU) ADHD
2.4.4.8. MIM-D3: dry eye disease
2.4.4.9. EGP-437: dry eye disease
2.4.4.10. EBI-005: dry eye disease
2.4.4.11. RU-101: dry eye disease
2.4.4.12. OTX-DP: dry eye disease
2.4.5. R&D scenario in ophthalmology market
2.4.5.1. Plasma technology in ophthalmology
2.4.5.2. Cornial topography & cornial analysis
2.4.5.3. Scope of virtual reality technology in eye care
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies

Browse For Same Category: http://www.acutemarketreports.com/category/pharmaceutical-market

2.5.3. Case studies: top competitive moves
2.6. Value chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions

3. Market determinants
3.1. Market drivers
3.1.1. FDA approvals giving rise to adoption of drugs and devices
3.1.2. Global increase in elderly population giving rise to ophthalmology market
3.1.3. Technological advancement
3.1.4. Innovation giving rise to ophthalmology drug and device market
3.1.5. Global increase in prevalence rates of eye diseases
3.1.6. Global increase in adoption of ophthalmology therapies and drugs
3.1.7. Global increase in healthcare expenditure
3.1.8. Global increase in minimally invasive surgeries
3.1.9. High prevalence rates of refractive errors driving the surgeries in ophthalmology market
3.2. Market restraints
3.2.1. Major drugs going off patent is affecting the growth of ophthalmology market
3.2.2. Drying pipelines is a concern for major players
3.3. Market challenges
3.3.1. Risk associated with the ocular diseases
3.3.2. Creating awareness for ophthalmology drug and device market
3.3.3. Global economic slowdown may affect the ophthalmology drug and device market
3.4. Market opportunities
3.4.1. Intraocular lenses, phacoemulsification devices and increasing cataract surgeries to create opportunities in emerging economies
3.4.2. Untapped APAC region has huge scope for ophthalmology drug and device market
3.4.3. Increase in diabetic retinopathies rising the demand for vitreoretinal surgeries

Request For The Sample: http://www.acutemarketreports.com/request-free-sample/58507

About – Acute Market Reports:

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.

Name: Chris Paul

ACUTE MARKET REPORTS

Designation: Global Sales Manager

Toll Free(US/CANADA): +1-855-455-8662

Email:  sales@acutemarketreports.com

Website: http://www.acutemarketreports.com

Share this post